Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of Alogliptin, once daily (QD), taken by
itself and with pioglitazone on postprandial lipid measures in type 2 diabetes.